MYLK and prostate neoplasm: Due to the central role played by the cytoskeleton in cell division and motility, it has been demonstrated that MYLK inhibition induces apoptosis in mammary prostate cancer cells and inhibits the growth of mammary and prostate tumors in rats and mice [24].